The Significance of Brain Damage in Persistent Oral Dyskinesia
By H. EDWARDS
In thelast tenyearsthere have been a number of studies reporting an association between certain persistent oral dyskinesias in elderly people (particularly women) and prolonged medication with phenothiazines.
Many of the casesdescribedin thesestudiesalso showed some evidenceofbraindamage and becauseof thisit has often been suggestedthat brain damage isan importantcontributory causeof oral dyskinesia. Buccal factorssuch as the edentulous state have also been incriminated (Joyston-Bechal, 1965; Evans, 1965) . However, very few controlled studies have been carried out. The literature on thissubjecthas been wellreviewed by Crane (1968) and Kline(1968) .
In a previouspaper (Pryceand Edwards, 1966 ) the totalphenothiazine intakeand the incidenceof brain damage were estimatedin twenty-oneelderly chronicpsychiatric female patients with persistent oraldyskinesia and in a control group oftwenty-one patients matched for sex, age, type and length of illness. The total phenothiazine intake was significantly greater in the dyskinetic group. The incidence of braindamage was very high and therewas no difference between the two groups.Possible reasons for this were discussed, and it was stated that a rigid test would require a separate studyin which caseswith oraldyskinesia were compared with a control group matched for phenothiazine intake.
This was the purpose of the present study, in which the incidence of brain damage and buccal abnormalities was estimated in a group of women who showed oral dyskinesia and in a control group matched forage,sex,and total phenothiazine intake. Itwas postulated thatthe dyskinetic group would show a significant excess of brain damage.
METHOD AND SUBJECTS
Initially a surveywas made of 131patients in threelong-stay femalewards ina mentalhospi tal, and then, in order to obtain an adequate number of matched controls, a furtherfifty threepatients from otherwardswere seen. Thus
patients
were reviewed in all. The presence or absence of abnormal movements in any part of the body was noted on a check-list for each pa tient. As was noted in the previous study (Pryce and Edwards, 1966) , abnormal movements of lips, tongue and jaws variedconsiderably bothinseverity and persistence. In view ofthis, each case which showed such movements was classified assevere, moderate,mild or doubtful. The numbers placed in each categorywere: severe,sixteen;moderate, eighteen;mild, fifteen; doubtful, twenty-two; absent,I53.The severeand moderate categories were combined to give an experimental group of thirty-four cases.
The totalphenothiazineintake was then measured for all the cases in the experimental group and in thosewho showed no abnormal movements. Each patientin the experimental group was then matched for age and total phenothiazine intakewith one who showed no dyskinesia. Matching forage was withina five yearrangeand phenothiazine intaketoplusor minus 25 per cent. The only two exceptions were one patient in theexperimental group who was matched with a patient six years older, and another who was matched with a patient eight years younger. Data on the two groups are given in Table I . It will be seen that the groups are well matched for age and pheno thiazine intake. Any medicationwith pheno thiazines was discontinued in the experimental group shortly after they were first seen. Pheno 
Localfactors
The presence or absence of teeth or dentures was noted.
Statistical analysis was by the chi-square test using Yates' correctionfor small numbers.
TANLEII

Comparison of experimental (E) and control (C) groups (i)
TANLE I
Data on experimental (E) and control (C) group
(ii) Total plienothiazine intake (weeks on the standard dose)
Measurement ofphenothiazine intake
A detailed description of the way in which drug intake was measured is given in the previous paper (Pryce and Edwards, 1966) . The prin ciple was to reduce the dosages of the various phenothiazines to a common unit, defined as the standard dose for each drug given for one week. The total number of units of drugs pre scribed was calculated for each patient in the experimental group and for all the patients who showed no abnormal movements.
Assessment of brain damage
As described in the previous paper (Pryce and Edwards, 1966), brain damage was judged to be present when there was firm evidence of any one of the following: organic psychiatric syndrome, leucotomy, any of the signs of â€oe¿ organicityâ€• listed by Shapiro et al. (1956) (i.e. focal cerebral attacks, confusional episodes, incontinence, character change, neurological
RESULTS
Comparison of experi mental and control groups
Table11(i) and (ii) gives dataon diagnosis and length of current admission in experimental and control groups. It will be seen that there is a marked preponderance of dementia in the experimental group. There is a preponderance of schizophrenics in the control group, and this As can be seen from Table III (i) and (ii), when each of the criteria (signs of â€oe¿ organicityâ€•, diagnosis of organic psychiatric syndrome, failure with Word Learning Test) are studied separately there is again a significant difference between the two groups. 
T,irn.E III
Evidence of brain damage in experimental (E) and control (C) groups
Electroconvulsivetherapy
Eleven patients in the experimental group had had ECT (mean number of treatments was twenty-six), and eight of the control group (mean number of treatments was thirty-six).
It is unlikely that this number of treatments would have caused brain damage.
Localfactors
Seventeensubjects in theexperimental group
were without teeth or dentures as compared with only ten in the control group, but this difference is not statistically significant (X2 = 2@5,d.f. = I,p>O@O5). although two of these had restarted pheno thiazines less than two months after stopping. These were all patients with a functional diag nosis, one of them showing no evidence of brain damage. However, in five experimental group cases the movements were rated as being more severe on re-assessment, although they had all then been off phenothiazines for at least thirty weeks. All but one of these showed evidence ofbrain damage.
Effect of discontinuing phenothiazines
Two control group cases had developed dyskinesia by the time of re-examination. One was seen to be constantly chewing or pursing her lips and this dyskinesia was so marked as to have warranted her inclusion in the experi mental group had it been present initially. This patient had taken 269 units, i.e. five years on standard doses of phenothiazines.
Another was noted to be intermittently pursing her lips or pushing her tongue against her lower lip. These movements were, however, only rated as â€oe¿ mildâ€• in severity. This patient had taken eighty-three units, i.e. over eighteen months on standard doses of phenothiazines. Both of these patients showed evidence of brain damage.
Nineteen cases in the experimental group had not re-started phenothiazine treatment at the time of re-examination.
In only one case did the movements appear to be definitely less severe, while in five, as noted above, they were thought to have become more severe. Only four of these nineteen cases showed no evidence of brain damage. The dyskinesia persisted after drug withdrawal for the following intervals:
fifteen weeks, one subject; thirty-two weeks, one subject; forty-four to forty-nine weeks, three subjects; fifty-four to fifty-six weeks, elevensubjects; 250â€"500 weeks,threesubjects.
In the majority, therefore, it had lasted for approximately twelve months after pheno thiazines were discontinued.
DIscussIoN
The data support the postulatethat the persistent oral dyskinesias observed in elderly women in mental hospitals are associated with a high incidence of brain damage, and sub stantiate the widely held opinion that brain damage may predispose to dyskinesia. The difference in the incidence of cases showing evidenceof brain damage on more than one criterion in the experimental and control groups (Table III ( iii)) is particularly striking. It is also worth noting that among patientswith functional psychiatric illnesses (Table III ( iv) )the incidenceof caseswith evidence of brain damage remains significantly greater among the dyskinetic group than the non-dyskineticgroup, i.e.it is not only the unequal distribution between Groups E and C of patients diagnosed as organic dementia which accounts for the differences shown in Table  III (iii).
In the previous paper (Pryce and Edwards, 1966) it was shown that a group of patients with oral dyskinesia had a significantly greater total phenothiazine intake than a control group. It is generally held that phenothiazine deri vatives may induce fits in patients with brain damage and increase the frequency of fits in epileptics (Hollister, 1961 still to be found after three to four months he insists that a minimum of six months should be required to label the condition, even tentatively, as irreversible. In this study, however, all but two of the nineteen subjects who had not re commenced phenothiazines at the time of re-examination had been off these drugs for at least forty-four weeks. In only one of these cases had the dyskinesia clearly improved, and in five it was thought to be more severe.
There was a predominance of subjects with out teeth or dentures in the experimental group, although this difference was not statisti cally significant. Similar findings were obtained in the previous study (Pryce and Edwards, 1966) and were discussed there.
SUMMARY
The incidence of brain damage and buccal abnormalities was estimated in thirty-four elderly chronic female patients with persistent oral dyskinesia and in a control group of thirty four patients matched for sex, age and pheno.. thiazine intake. The incidence of brain damage was significantly greater in the dyskinetic group, but there was no significant difference in the incidence of buccal abnormalities. The significance of these results is discussed.
